Acumen Pharmaceuticals (ABOS) Amortizatization of Intangibles (2021 - 2026)

Acumen Pharmaceuticals has reported Amortizatization of Intangibles for 6 years, with the latest figure at -$25000.0 in Q1 2026.

• Quarterly Amortizatization of Intangibles fell 104.25% year-over-year to -$25000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $196000.0 (down 94.9% YoY) and the FY2025 annual result came in at $809000.0, down 83.87% from the prior year.
• Amortizatization of Intangibles advanced to -$25000.0 in Q1 2026 per ABOS's latest filing, from -$110000.0 in the prior quarter.
• Over five years, Amortizatization of Intangibles peaked at $1.8 million in Q4 2023 and troughed at -$216000.0 in Q1 2022.
• A 5-year average of $496058.8 and a median of $300000.0 in 2023 frame the typical range for Amortizatization of Intangibles.
• The sharpest annual moves came in 2023 and 2025: Amortizatization of Intangibles soared 1919.32% in 2023, then plunged 126.44% in 2025.
• Over 5 years, Amortizatization of Intangibles stood at $88000.0 in 2022, then jumped by 1919.32% to $1.8 million in 2023, then tumbled by 76.59% to $416000.0 in 2024, then sank by 126.44% to -$110000.0 in 2025, then soared by 77.27% to -$25000.0 in 2026.
• According to Business Quant data, Amortizatization of Intangibles over the past three periods registered -$25000.0, -$110000.0, and $275000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.